Semler Scientific以1000万美元的价格收购了111个比特币，将其持股量达到3,303 BTC

此次收购将Semler Scientific的持股量带到了3,303个比特币。

Medical technology company Semler Scientific announced the acquisition of 111 more bitcoins (BTC) for $10 million between February 14 and April 24.

医疗技术公司Semler Scientific宣布在2月14日至4月24日之间以1000万美元的价格收购了111个比特币（BTC）。

Semler Scientific Announces New BTC Holdings

Semler Scientific宣布了新的BTC控股

Semler Scientific (Nasdaq: SMLR) disclosed that it bought the coins for an average price of $90,124 per bitcoin using net proceeds from its at-the-market (ATM) offering program and available cash.

Semler Scientific（NASDAQ：SMLR）透露，它使用其在市场（ATM）发行计划和可用现金的净收益购买了每比特币90,124美元的硬币。

The additional bitcoins brought Semler Scientific’s holdings to 3,303 bitcoins purchased for a total of $290.4 million at an average price of $87,929 per bitcoin. The market value of Semler Scientific’s BTC holdings on April 24 at 4 p.m. EDT was $309.1 million.

额外的比特币将Semler Scientific的股份带到了3,303个比特币，总计2.904亿美元，平均价格为每比特币87,929美元。 EDT 4月24日下午4点，Semler Scientific的BTC持有的市场价值为3.091亿美元。

The latest BTC holdings update comes a little over a week after Semler Scientific filed for a $500 million mixed-securities offering to fund further bitcoin acquisitions.

最新的BTC控股更新是在Semler Scientific申请了5亿美元的混合安全产品以资助更多比特币收购后的一周多了一周的时间。

The filing permits Semler Scientific to sell debt securities, common stock or units and use the proceeds primarily to buy more BTC.

该文件允许Semler Scientific出售债务证券，普通股或单位，并主要使用收益购买更多BTC。

To support its bitcoin purchases, Semler Scientific had been utilizing a new Controlled Equity Offering Sales Agreement.

为了支持其比特币购买，Semler Scientific一直使用新的受控权益提供销售协议。

The medical technology company disclosed that it had initially entered into an agreement with Cantor Fitzgerald, commencing in January 2025, for the sale of shares of its common stock to generate proceeds to fund bitcoin acquisitions.

这家医疗技术公司透露，它最初与坎托·菲茨杰拉德（Cantor Fitzgerald）达成了一项协议，该协议于2025年1月开始，以出售其普通股以产生收益以资助比特币收购。

Through this agreement, Semler Scientific issued and sold 2,438,274 shares for net proceeds of approximately $126 million. Following the effectiveness of a new ATM equity offering program on April 22, 2025, Semler Scientific ceased selling shares under the initial agreement with Cantor Fitzgerald.

通过这项协议，Semler Scientific发行并出售了2,438,274股，净收益约为1.26亿美元。在2025年4月22日新的ATM股权产品计划的有效性之后，Semler Scientific停止根据与Cantor Fitzgerald的初步协议出售股票。

However, the company announced that it had closed a new ATM offering with Barclays Capital, Cantor Fitzgerald, Canaccord Genuity LLC, Point72 Ventures and Ridge Capital Partners on April 23, 2025. This new offering allows Semler Scientific to issue and sell up to $500 million in common stock.

但是，该公司宣布已于2025年4月23日与巴克莱资本，Cantor Fitzgerald，Canaccord Genuity LLC，Point72 Ventures和Ridge Capital Partners关闭了新的ATM产品。这项新产品允许Semler Scientific发行并出售高达5亿美元的普通股。

As of April 24, Semler Scientific had sold 57,100 shares under this new offering, generating approximately $2 million in net proceeds.

截至4月24日，Semler Scientific在此新产品下售出了57,100股，产生了约200万美元的净收益。

According to the statement, Semler Scientific reported a 23.5% year-to-date BTC yield through April 24, 2025. The company uses BTC yield as a key performance indicator (KPI) to evaluate its bitcoin acquisition strategy and assess its impact on stockholders.

根据声明，Semler Scientific报告到2025年4月24日，年初至今的BTC收益率为23.5％。该公司使用BTC收益率作为关键绩效指标（KPI）来评估其比特币获取策略，并评估其对股东的影响。

Semler Scientific believes this KPI is useful to investors seeking to understand its decision to fund the purchase of BTC by issuing additional shares of its common stock or instruments convertible to common stock.

Semler Scientific认为，该KPI对寻求了解其决定购买BTC的决定的投资者很有用，该决定通过发行其普通股或可转换为普通股的工具的其他股份来购买BTC。